PDF(Pubmed)
Abstract：
The application of a robotic platform in the bariatric surgical field is intended to enhance the already established advantages of minimally invasive surgery in terms of both technical and clinical outcomes. These advantages are especially relevant for technically challenging multiquadrant operations such as Roux-en-Y Gastric Bypass (RYGB). Consequently, robotic-assisted surgery has emerged as a possible application for bariatric surgeries. The study attempts to assess feasibility and safety of the Hugo™-Robotic-Assisted Surgery System (Hugo™-RAS) platform compared to the DaVinci® Surgical System (DaVinci®-SS) with a focus on complication rates and operative times. We retrospectively reviewed bariatric procedures performed from January 2013 until December 2023. We included all robotic RYGBs performed using Hugo™-RAS and DaVinci®-SS platforms. The study utilized Propensity Score Matching (PSM) analysis to address bias in selection, matching patients based on age, gender, body mass index, comorbidities and past abdominal operations. One hundred thirty-five patients were identified: 90 DaVinci®-SS and 45 Hugo™-RAS procedures. After PSM, each group consisted of 45 patients. There was no discernible disparity observed in relation to early (≤ 30 days) postoperative complications rate (p = 1), mean operative time (for docking time, console time and total operative time: p = 0.176, p = 0.678, p = 0.229, respectively) and postoperative hospital stay (p = 0.052) between DaVinci®-RSS and Hugo™-RAS procedures. Our results suggest that application of both Hugo™-RAS and DaVinci®-SS robotic platforms to RYGB is related to comparable safety profiles. Although DaVinci®-SS remains the most widely adopted platform in clinical practice, this study underscores the potential role of the Hugo™-RAS to provide effective solutions in robotic bariatric procedures.
摘要：
机器人平台在减肥手术领域的应用旨在增强微创手术在技术和临床结果方面已经确立的优势。这些优点对于诸如Roux-en-Y胃旁路(RYGB)的具有技术挑战性的多象限操作尤其相关。因此,机器人辅助手术已成为减肥手术的可能应用。该研究试图评估Hugo™机器人辅助手术系统（Hugo™-RAS）平台与DaVinci®手术系统（DaVinci®-SS）的可行性和安全性，重点是并发症发生率和手术时间。我们回顾性回顾了从2013年1月至2023年12月进行的减肥手术。我们包括使用Hugo™-RAS和DaVinci®-SS平台执行的所有机器人RYGB。这项研究利用倾向得分匹配(PSM)分析来解决选择中的偏见，根据年龄匹配患者，性别,身体质量指数,合并症和过去的腹部手术。鉴定了一百三十五个患者:90个DaVinci®-SS和45个Hugo™-RAS程序。PSM之后,每组45例患者.早期（≤30天）术后并发症发生率没有明显差异（p=1），平均手术时间(对接时间，控制台时间和总手术时间：分别为p=0.176，p=0.678，p=0.229）和DaVinci®-RSS和Hugo™-RAS程序之间的术后住院时间（p=0.052）。我们的结果表明，将Hugo™-RAS和DaVinci®-SS机器人平台应用于RYGB与可比的安全性有关。尽管DaVinci®-SS仍然是临床实践中采用最广泛的平台，这项研究强调了Hugo™-RAS在机器人减肥手术中提供有效解决方案的潜在作用.
